Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

516
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
516
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

461
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
461
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

879
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
879
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

800
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
800
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High prevalence of malnutrition and sarcopenia in patients with NTM pulmonary disease: results from an Italian prospective multicentre study.

Respiratory research·2026
Same author

Treating tuberculosis without rifampicin: an open dilemma.

Respiratory medicine·2026
Same author

The multifaceted antiretroviral coverage provided by BIC/FTC/TAF: a pharmacokinetic/pharmacodynamic revisitation.

Le infezioni in medicina·2026
Same author

Individualized TB care for drug-susceptible pulmonary tuberculosis: clinical alternatives when HRZE is contraindicated or not tolerated.

Expert review of respiratory medicine·2026
Same author

Plasma central nervous system biomarkers in heavily treatment-experienced people with HIV in the PRESTIGIO registry.

AIDS (London, England)·2026
Same author

A Methodology for Creating Patient Relevant Questions Suitable for Evaluating AI Generated Health Advice.

Studies in health technology and informatics·2026

Related Experiment Video

Updated: Jan 6, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.4K

Post-tuberculosis lung disease: a guide for clinicians.

Giovanni Fumagalli1,2,3, Jessica Mencarini4,5, Irene Sini6,4

  • 1TB Regional Reference Centre and Laboratory, ASST Grande Ospedale Metropolitano Niguarda-Villa Marelli Institute, Milan, Italy. giovanni.fumagalli@ospedaleniguarda.it.

Infection
|September 25, 2025
PubMed
Summary

Post-tuberculosis lung disease (PTLD) significantly impacts TB survivors

Keywords:
Post TB lung diseaseTB managementTB sequelaeTuberculosis

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.5K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K

Related Experiment Videos

Last Updated: Jan 6, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.4K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.5K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Public Health

Background:

  • Post-tuberculosis lung disease (PTLD) is a growing concern affecting TB survivors' quality of life.
  • PTLD encompasses diverse lung impairments (e.g., fibrosis, bronchiectasis) persisting after TB cure.
  • High PTLD burden exists globally, exacerbated by delayed diagnosis and inadequate treatment.

Purpose of the Study:

  • To review current evidence on PTLD epidemiology, diagnosis, and management.
  • To provide practical guidance for clinicians managing TB survivors.
  • To identify research gaps and future directions for PTLD.

Main Methods:

  • Narrative review of existing literature on PTLD.
  • Synthesis of data on PTLD prevalence, clinical evaluation, and treatment strategies.
  • Analysis of current diagnostic and therapeutic pathways.

Main Results:

  • PTLD presents with various structural and functional lung abnormalities.
  • Spirometry and imaging are crucial for diagnosing persistent lung damage in TB survivors.
  • Multidisciplinary care involving medication, rehabilitation, and potentially surgery is key.

Conclusions:

  • Standardized PTLD diagnostic and treatment guidelines are currently lacking.
  • Further research is needed on optimal follow-up, rehabilitation, and prevention.
  • Prospective studies and patient education are essential to reduce PTLD morbidity and mortality.